在小鼠的高盐诱导胸前大动脉内皮功能障碍中,eNOS的O-GlcNAcylation
Chang Li1,2, Liuming Gao1,2, Yi Ling1,2
1Department of Cardiology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Frontiers in pharmacology
|January 1, 2026
概括
高盐摄入量会通过通过增加eNOS的O-GlcNAc修饰来损害内皮功能,从而提高透气血压. 抑制O-GlcNAc转移酶 (OGT) 逆转了这些效应,表明盐引起的高血压的治疗标.
科学领域:
- 心血管研究研究心血管研究
- 内皮细胞生物学 内皮细胞生物学
- 高血压的分子机制 高血压的分子机制
背景情况:
- 过度摄入盐是高血压的已知危险因素.
- 将盐诱导的内皮功能障碍与血压升高联系起来的精确分子通路尚未完全理解.
研究的目的:
- 调查高盐摄入导致内皮功能障碍并导致扩张性血压升高的分子机制.
- 探索O-GlcNAc对内皮氧化合成酶 (eNOS) 的修饰在盐引起的高血压中的作用.
主要方法:
- 给小鼠提供了正常盐或高盐的饮食,并用NaCl处理了初级牛大动脉内皮细胞 (BAECs).
- 血管功能通过血管扩张反应进行评估.
- 在 eNOS O-GlcNAc 修饰和 OGT 表达的分析中,使用了西方的 blot.
- 评估了一种OGT抑制剂 (OSMI-1) 的作用.
主要成果:
- 在小鼠中,高盐饮食诱导了扩张性血压升高和受损的内皮依赖血管扩张.
- 高盐减少了BAEC的扩散,迁移和管道形成.
- 高盐增加了ENOS O-GlcNAc修饰和OGT表达,降低了氧化的生物利用性.
- 通过OSMI-1治疗,可以逆转内皮功能障碍并恢复血管扩张.
结论:
- 高盐摄入量会损害内皮功能,并通过增强eNOS O-GlcNAc修饰来提高透气血压.
- 抑制OGT可以有效地逆转盐引起的内皮功能障碍.
- 准eNOS O-GlcNAc修饰是一种潜在的治疗策略,用于管理盐引起的高血压.
更多相关视频
10:28Evaluation of Vascular Control Mechanisms Utilizing Video Microscopy of Isolated Resistance Arteries of Rats
Published on: December 5, 2017
9.7K
05:31Murine Model of Thoracic Aortic Dissection Induced by Oral β-Aminopropionitrile and Subcutaneous Angiotensin II Infusion
Published on: May 16, 2025
779
相关概念视频
01:28Nitric Oxide Signaling Pathway
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
01:27Esophageal Achalasia
Esophageal achalasia is a chronic neurogenic disorder characterized by impaired relaxation of the lower esophageal sphincter (LES) and absent or ineffective peristalsis in the distal esophagus. This leads to a functional obstruction without a physical blockage, despite significant disruption of esophageal motility.EtiologyAchalasia is caused by degeneration of the myenteric (Auerbach's) plexus, specifically the loss of inhibitory ganglion cells that produce vasoactive intestinal peptide (VIP)...